Correlation Between Rigel Pharmaceuticals and Innovent Biologics
Can any of the company-specific risk be diversified away by investing in both Rigel Pharmaceuticals and Innovent Biologics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Rigel Pharmaceuticals and Innovent Biologics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Rigel Pharmaceuticals and Innovent Biologics, you can compare the effects of market volatilities on Rigel Pharmaceuticals and Innovent Biologics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Rigel Pharmaceuticals with a short position of Innovent Biologics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Rigel Pharmaceuticals and Innovent Biologics.
Diversification Opportunities for Rigel Pharmaceuticals and Innovent Biologics
-0.5 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Rigel and Innovent is -0.5. Overlapping area represents the amount of risk that can be diversified away by holding Rigel Pharmaceuticals and Innovent Biologics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Innovent Biologics and Rigel Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Rigel Pharmaceuticals are associated (or correlated) with Innovent Biologics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Innovent Biologics has no effect on the direction of Rigel Pharmaceuticals i.e., Rigel Pharmaceuticals and Innovent Biologics go up and down completely randomly.
Pair Corralation between Rigel Pharmaceuticals and Innovent Biologics
Given the investment horizon of 90 days Rigel Pharmaceuticals is expected to generate 1.83 times more return on investment than Innovent Biologics. However, Rigel Pharmaceuticals is 1.83 times more volatile than Innovent Biologics. It trades about 0.16 of its potential returns per unit of risk. Innovent Biologics is currently generating about 0.04 per unit of risk. If you would invest 977.00 in Rigel Pharmaceuticals on September 3, 2024 and sell it today you would earn a total of 1,784 from holding Rigel Pharmaceuticals or generate 182.6% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 99.21% |
| Values | Daily Returns |
Rigel Pharmaceuticals vs. Innovent Biologics
Performance |
| Timeline |
| Rigel Pharmaceuticals |
| Innovent Biologics |
Rigel Pharmaceuticals and Innovent Biologics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Rigel Pharmaceuticals and Innovent Biologics
The main advantage of trading using opposite Rigel Pharmaceuticals and Innovent Biologics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Rigel Pharmaceuticals position performs unexpectedly, Innovent Biologics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Innovent Biologics will offset losses from the drop in Innovent Biologics' long position.| Rigel Pharmaceuticals vs. Fortress Biotech | Rigel Pharmaceuticals vs. Reviva Pharmaceuticals Holdings | Rigel Pharmaceuticals vs. Pieris Pharmaceuticals | Rigel Pharmaceuticals vs. Cidara Therapeutics |
| Innovent Biologics vs. Telix Pharmaceuticals Limited | Innovent Biologics vs. Keros Therapeutics | Innovent Biologics vs. MAIA Biotechnology | Innovent Biologics vs. Clarity Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.
Other Complementary Tools
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device |